Document Detail


Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience.
MedLine Citation:
PMID:  21505945     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Anticonvulsant therapy is usually recommended before surgery in all patients affected by high grade glioma who are planned to be treated with Carmustine 1,3-bis [2 chloroetyl]-1-nitrosurea, or BCNU) wafers. In fact, phase III studies have reported a risk of seizures higher than 30% in this group of patients. The aim of the study was the evaluation of rate type time of occurrence of seizures in BCNU-treated patients in the postoperative period as well as the investigation into possible risk factors for seizure occurrence in this population. From April 2007 to September 2010, 55 patients underwent surgical removal of malignant glioma and BCNU wafers implantation at the Department of Neurosurgery of Padova. All patients were given antiepileptic prophylaxis for 3 months after surgery. Clinical data (including preoperative seizure history), radiological data, surgical treatment, antiepileptic treatment were retrospectively reviewed. Nine percent of the patients treated with BCNU wafers presented seizures in the postoperative course. Seizures were partial in 80% of cases; they occurred within 30 days after surgery and in 80% of cases within the first 7 days. Patients with preoperative seizures presented more frequently postoperative epilepsy than patients who were preoperatively seizure-free [P = 0.0006; OR = 48 (2,4;945)]. Postoperative seizures were more common among patients affected by one or more wafers related adverse event than among patients without adverse events [P = 0.006; OR = 21 (2,06;213)]; however, they did not appear associated to the number of implanted wafers. Patients with a sub-therapeutic level of AED at the seventh day after surgery presented a higher seizure occurrence [P = 0.02; OR = 11 (1,5;79,8)]. In our experience, postoperative seizures in BCNU-treated patients were less frequent than expected. Careful patient selection and postoperative monitoring could probably play a role in order to decrease seizure occurrence.
Authors:
Alessandro Della Puppa; Luca Denaro; Marta Rossetto; Pietro Ciccarino; Renzo Manara; Giuseppe Lombardi; Giulia Del Moro; Antonino Rotilio; Domenico d'Avella; Renato Scienza
Related Documents :
21145195 - Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal...
16621035 - Bilateral epistaxis in children: efficacy of bilateral septal cauterization with silver...
21331125 - Esophageal stenting.
19379615 - Preoperative prognostic factors for olfactory change after functional endoscopic sinus ...
24583855 - Efficacy and safety profile comparison of colistin and tigecycline on the extensively d...
16822395 - Management of symptomatic intracranial arterial stenosis: endovascular therapy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-20
Journal Detail:
Title:  Journal of neuro-oncology     Volume:  -     ISSN:  1573-7373     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309335     Medline TA:  J Neurooncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Neurosurgery, Padova University Hospital, Via Giustiniani 2, Azienda Ospedaliera di Padova, 35128, Padova, Italy, alessandro.dellapuppa@sanita.padova.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship between different spectral forms of the protochlorophyllide oxidoreductase complex ...
Next Document:  Mapping unexplored genomes II: genetic architecture of species differences in the woody Sonchus alli...